Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • AUD/USD

    0.6509
    +0.0020 (+0.31%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.51
    +0.15 (+0.18%)
     
  • GOLD

    2,336.20
    -5.90 (-0.25%)
     
  • Bitcoin AUD

    102,586.59
    +907.82 (+0.89%)
     
  • CMC Crypto 200

    1,419.97
    -4.13 (-0.29%)
     

Is Doximity's Stock Still Too Expensive to Buy?

Is Doximity's Stock Still Too Expensive to Buy?

Ever since Doximity (NYSE: DOCS) went public in June 2021, the stock has been commanding a significant premium. Unsurprisingly, as investors have become more focused on valuations and earnings multiples, shares of Doximity have been falling in value and are down 38% year to date. Investors may be wondering if this has created a buying opportunity for a business that still sees plenty of growth in its future.